| | Variable | MI patients with no coronary artery occlusion | MI patients with coronary artery occlusion | Pearson , |
| | Gender | | | | | Men, (%) | 49 (59.0) | 201 (68.6) | | | Women, (%) | 34 (41.0) | 92 (31.4) | | | Total, (%) | 83 (100.0) | 293 (100.0) | 2.656, | | Age in years | | | | | Men, mean ± SD | 60.87 ± 9.48 | 60.37 ± 11.36 | | | Median (min–max) | 63 (36–79) | 61 (31–87) | | | Women, mean ± SD | 65.20 ± 9.79 | 68.27 ± 10.75 | | | Median (min–max) | 66 (42–79) | 70 (37–86) | | | Total, mean ± SD | 62.65 ± 9.79 | 62.85 ± 11.74 | | | Median (min–max) | 65 (36–79) | 64 (31–87) | | | Arterial hypertension | | | | | Men | 46 (55.4) | 164 (56.0) | 4.424, | | Women | 31 (37.4) | 83 (28.3) | 0.027, | | Total | 77 (92.8) | 247 (84.3) | 3.894, | | BMI > 30 kg/m2 | | | | | Men | 15 (18.1) | 63 (21.5) | 0.010, | | Women | 10 (12.0) | 42 (14.3) | 2.701, | | Total | 25 (30.1) | 105 (35.8) | 0.934, | | Diabetes | | | | | Men | 1 (1.2) | 24 (8.2) | 4.290, | | Women | 4 (4.8) | 17 (5.8) | 0.806, | | Total | 5 (6.0) | 41 (14.0) | 3.825, | | Dyslipidaemia in anamnesis | | | | | Men | 40 (48.2) | 150 (51.2) | 1.379, | | Women | 27 (32.5) | 79 (27.0) | 0.309, | | Total | 67 (80.7) | 229 (78.2) | 0.630, | | PAI-1 genotype distribution according to the patient gender | | | | | Men: | | | | | 4G/4G | 17 (20.4) | 64 (21.8) | 2.198, | | 4G/5G | 20 (24.1) | 103 (35.1) | | | 5G/5G | 12 (14.5) | 34 (11.6) | | | Women: | | | | | 4G/4G | 13 (15.7) | 28 (9.6) | 2.736, | | 4G/5G | 13 (15.7) | 50 (17.1) | | | 5G/5G | 8 (9.6) | 14 (4.8) | | | Total | | | | | 4G/4G | 30 (36.1) | 92 (31.4) | 4.607, | | 4G/5G | 33 (39.8) | 153 (52.2) | | | 5G/5G | 20 (24.1) | 48 (16.4) | | | MAF | 0.43 | 0.42 | |
|
|
